Navigation Links
December GEOLOGY and GSA TODAY media highlights
Date:11/29/2007

ng the PermianTriassic crisis
Shuceng Xie et al., China University of Geosciencess, Key Laboratory of Biogeology and Environmental Geology, Wuhan, Hubei 430074, China. Pages 1083-1086.

Earth witnessed its most severe mass extinction 250 million years ago. This extinction has been thought to be abrupt and probably caused by an extraterrestrial impact. However, Xie et al. present several lines of geochemical evidence from a South China section (an optimal section to study the biotic crisis) that indicates a two-episodic global change in association with the ecological crisis. The global carbon cycle, the enhanced terrestrial weathering, the marine photic zone euxinia, the faunal mass extinction, and the cyanobacterial expansion all occurred as two episodes, showing a close coupling among the ocean, the atmosphere, and the land system at that time. In particular, Xie et al. found that the first episode occurred before the presumed bolide impact. The temporal sequence of these two events suggests that the biotic crisis was a consequence of prolonged and episodic changes in the marine and continental systems, and argues against an extraterrestrial impact as the main cause.


Orbital rhythms, monsoons, and playa lake response, Olduvai Basin, equatorial East Africa (ca. 1.851.74 Ma)
Gail Ashley, Rutgers, The State University of New Jersey, Geological Sciences, 610 Taylor Road, Piscataway, New Jersey 08854-8066, USA. Pages 1091-1094.

Early humans evolved in Africa during times of increasing aridity and climate variability. Olduvai Gorge, Tanzania (near the equator) has been an important site for human origin research since its discovery in the 1930s. The Gorge exposes a 100,000-year-long record at the Plio-Pleistocene boundary that contains a rich vertebrate fossil record, two species of hominins, thousands of stone tools, and a detailed paleoenvironmental record. Ashleys recent geological studies of Olduvai Basin reveale
'/>"/>

Contact: Ann Cairns
acairns@geosociety.org
303-357-1056
Geological Society of America
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10

Related biology news :

1. September Geology and GSA Today media highlights
2. October Geology and GSA Today media highlights
3. November GEOLOGY and GSA TODAY Media Highlights
4. Heart of Herschel to be presented to media
5. Last chance for media to register for ECCO 14 -- the European Cancer Conference
6. Media highlights in the November issues of Biophysical Journal
7. Nanotechnology and the media: The inside story
8. Highlights from the September 2007 Journal of the American Dietetic Association
9. AGU journal highlights -- Sept. 6, 2007
10. IDEMA Reveals Program Highlights for DISKCON USA 2007
11. IDEMA Reveals Program Highlights for DISKCON USA 2007
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):UCLA researchers engineer bacteria to turn carbon dioxide into liquid fuel 2Princeton scientists find way to catalog all that goes wrong in a cancer cell 2Berkeley Lab researchers participate in Homeland Security study of subway airflow 2Lockheed Martin Expands Health IT Business with 24170 Million in New Health 26amp 3B Human Services Contract Awards 60095 1Lockheed Martin Expands Health IT Business with 24170 Million in New Health 26amp 3B Human Services Contract Awards 60095 2Rcadia Medical Imaging Wins 2009 AuntMinnie com Best New Radiology Vendor Award 5701 1Rcadia Medical Imaging Wins 2009 AuntMinnie com Best New Radiology Vendor Award 5701 2Rcadia Medical Imaging Wins 2009 AuntMinnie com Best New Radiology Vendor Award 5701 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 1New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 2New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 4New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 5New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 6New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 7New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 8New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 9New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 10
Other Biology Technology:Shire's New Product Portfolio Delivers Strong Quarterly Performance 2Shire's New Product Portfolio Delivers Strong Quarterly Performance 3Shire's New Product Portfolio Delivers Strong Quarterly Performance 4Shire's New Product Portfolio Delivers Strong Quarterly Performance 5Shire's New Product Portfolio Delivers Strong Quarterly Performance 6Shire's New Product Portfolio Delivers Strong Quarterly Performance 7Shire's New Product Portfolio Delivers Strong Quarterly Performance 8Shire's New Product Portfolio Delivers Strong Quarterly Performance 9Shire's New Product Portfolio Delivers Strong Quarterly Performance 10Shire's New Product Portfolio Delivers Strong Quarterly Performance 11Shire's New Product Portfolio Delivers Strong Quarterly Performance 12Shire's New Product Portfolio Delivers Strong Quarterly Performance 13Shire's New Product Portfolio Delivers Strong Quarterly Performance 14Shire's New Product Portfolio Delivers Strong Quarterly Performance 15Shire's New Product Portfolio Delivers Strong Quarterly Performance 16Shire's New Product Portfolio Delivers Strong Quarterly Performance 17Shire's New Product Portfolio Delivers Strong Quarterly Performance 18Shire's New Product Portfolio Delivers Strong Quarterly Performance 19Shire's New Product Portfolio Delivers Strong Quarterly Performance 20Shire's New Product Portfolio Delivers Strong Quarterly Performance 21Shire's New Product Portfolio Delivers Strong Quarterly Performance 22Shire's New Product Portfolio Delivers Strong Quarterly Performance 23Shire's New Product Portfolio Delivers Strong Quarterly Performance 24Shire's New Product Portfolio Delivers Strong Quarterly Performance 25Shire's New Product Portfolio Delivers Strong Quarterly Performance 26Shire's New Product Portfolio Delivers Strong Quarterly Performance 27Shire's New Product Portfolio Delivers Strong Quarterly Performance 28Shire's New Product Portfolio Delivers Strong Quarterly Performance 29Shire's New Product Portfolio Delivers Strong Quarterly Performance 30Shire's New Product Portfolio Delivers Strong Quarterly Performance 31Shire's New Product Portfolio Delivers Strong Quarterly Performance 32Shire's New Product Portfolio Delivers Strong Quarterly Performance 33Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 2Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 3Sinovac to Participate in Two Upcoming Investor Conferences 2